Skip to main content

NHS Blood and Transplant: Artificial Intelligence

Question for Department of Health and Social Care

UIN 83490, tabled on 29 November 2021

To ask the Secretary of State for Health and Social Care, whether the NHS Blood and Transplant algorithm which decides how organs are allocated has been updated since the new drug Trikafta was introduced for cystic fibrosis sufferers.

Answered on

9 December 2021

NHS Blood and Transplant has a selection and allocation policy for each organ, ensuring a transparent process to balance reducing mortality on waiting lists and matching donor lungs with recipients to provide the best outcome for all listed patients. The algorithm is not dependent on the primary disease and patients are only placed on the transplant list after maximal therapy.

NHS Blood and Transplant’s Lung Advisory Group would regard a trial of Trikafta (Kaftrio) as an important pre-referral step and most cystic fibrosis physicians would prescribe this prior to the referral of patients for transplantation.